Nabriva Therapeutics plc Business Finance Contracts & Agreements

30 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Purchase Agreement by and among Nabriva Therapeutics Entities and Sumitomo Pharma Co., Ltd. dated July 30, 2023
Purchase Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2023
Purchase Agreement between Nabriva Therapeutics plc and Lincoln Park Capital Fund, LLC (September 24, 2021)
Purchase Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2021
Registration Rights Agreement between Nabriva Therapeutics plc and Lincoln Park Capital Fund, LLC (September 24, 2021)
Registration Rights Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2021
Second Amendment to Sales Promotion and Distribution Agreement among Nabriva Therapeutics Ireland DAC, MSD International GmbH, and Merck Sharp & Dohme Corp.
Modification Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NJ
2021
Assignment, Assumption and Novation Agreement among Roivant Sciences Ltd., Sumitomo Pharmaceuticals (Suzhou) Co., Ltd., and Nabriva Therapeutics
Assignment Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2021
Fourth Amendment to Loan and Security Agreement among Nabriva Therapeutics and Hercules Capital, Inc.
Loan Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2021
Nabriva Therapeutics Nonstatutory Share Option Agreement under 2021 Inducement Share Incentive Plan
Equity Distribution Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2021
Nabriva Therapeutics plc Share Option Agreement under 2020 Share Incentive Plan
Equity Distribution Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2021
Open Market Sale Agreement between Nabriva Therapeutics plc and Jefferies LLC (May 6, 2021)
Equity Distribution Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2021
Description of Securities Registered Under Section 12 of the Exchange Act – Nabriva Therapeutics plc
Equity Distribution Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2021
Securities Purchase Agreement between Nabriva Therapeutics plc and Purchasers dated March 1, 2021
Purchase Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2021
Nabriva Therapeutics plc Ordinary Share Pre-Funded Purchase Warrant Agreement
Warrant Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2021
Ordinary Share Purchase Warrant Agreement between Nabriva Therapeutics plc and Holder
Warrant Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2021
Securities Purchase Agreement between Nabriva Therapeutics plc and Purchasers (December 10, 2020)
Purchase Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2020
Securities Purchase Agreement between Nabriva Therapeutics plc and Purchasers (May 29, 2020)
Purchase Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2020
Ordinary Share Purchase Warrant between Nabriva Therapeutics plc and Holder (June 2020)
Warrant Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2020
Nabriva Therapeutics plc Share Option/Cash-Settled Share Appreciation Right Agreement under 2020 Share Incentive Plan
Equity Distribution Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2020
Third Amendment to Loan and Security Agreement among Nabriva Therapeutics and Hercules Capital, Inc.
Loan Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2020
Second Amendment to Loan and Security Agreement among Nabriva Therapeutics, Guarantors, and Hercules Capital, Inc.
Loan Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2020
Description of Registered Securities of Nabriva Therapeutics plc under Section 12 of the Exchange Act
Stock Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2020
Securities Purchase Agreement between Nabriva Therapeutics plc and Purchasers (December 20, 2019)
Purchase Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2019
Ordinary Share Purchase Warrant Agreement between Nabriva Therapeutics plc and Holder
Warrant Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2019
First Amendment to Loan and Security Agreement among Nabriva Therapeutics, Affiliates, and Hercules Capital
Loan Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2019
Open Market Sale Agreement between Nabriva Therapeutics plc and Jefferies LLC (June 25, 2019)
Equity Distribution Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2019
Loan and Security Agreement among Nabriva Therapeutics Entities and Hercules Capital, Inc. dated December 20, 2018
Loan Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2019
Stock Purchase Agreement among SG Pharmaceuticals, Inc., Sellers of Zavante Therapeutics, Inc., and Sellers’ Representative
Purchase Agreements
Nabriva Therapeutics plc
Pharmaceuticals
CA
2018
Nabriva Therapeutics plc Ordinary Shares Underwriting Agreement with Underwriters (July 26, 2018)
Underwriting Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2018
Controlled Equity Offering Sales Agreement between Nabriva Therapeutics plc and Cantor Fitzgerald & Co. (March 16, 2018)
Equity Distribution Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2018
Nabriva Therapeutics plc Share Option Agreement under 2017 Share Incentive Plan
Equity Distribution Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2018
Nabriva Therapeutics plc Ordinary Shares Underwriting Agreement with Underwriters (September 19, 2017)
Underwriting Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2017